• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.86% Nasdaq Up0.65%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    0.37 Down 0.00(0.73%) 10:44AM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development54,218  68,205  71,860  
    Selling General and Administrative13,392  15,746  15,699  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (67,610) (83,951) (87,559)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  
    Earnings Before Interest And Taxes(67,610)(83,951)(87,559)
    Interest Expense1,061  2,210  2,633  
    Income Before Tax(68,671)(86,161)(90,192)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(68,671)(86,161)(90,192)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (68,671) (86,161) (90,192)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (68,671) (86,161) (90,192)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.